| 12214051 |
Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR) |
Yuan Cheng, Chawita Netirojjanakul, Jerry Ryan HOLDER, James R. Falsey, Bradley J. Herberich +7 more |
2025-02-04 |
|
| 11795488 |
Methods for enzymatic peptide ligation |
Renliang Yang, Yee Hwa Wong, Julien LESCAR, Chuan-Fa Liu, James P. Tam +2 more |
2023-10-24 |
|
| 11732266 |
RNAi constructs for inhibiting ASGR1 expression and methods of use thereof |
Michael OLLMANN, Yang Li, Jun Zhang, Oliver HOMANN, Leslie P. Miranda +5 more |
2023-08-22 |
$391,798,000 |
| 10905772 |
Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR) |
Yuan Cheng, Chawita Netirojjanakul, Jerry Ryan HOLDER, James R. Falsey, Bradley J. Herberich +7 more |
2021-02-02 |
$295,872,000 |
| 10870856 |
RNAi constructs for inhibiting ASGR1 expression and methods of use thereof |
Michael OLLMANN, Yang Li, Jun Zhang, Oliver HOMANN, Leslie P. Miranda +4 more |
2020-12-22 |
$864,393,000 |
| 10344060 |
Potent and selective inhibitors of Nav1.7 |
Justin K. MURRAY, Jerry Ryan HOLDER, Malgorzata Wanska, Christopher M. Tegley, James R. Falsey +5 more |
2019-07-09 |
$101,446,000 |
| 10188656 |
Methods of treatment of malignancies |
Sung Eun Choe |
2019-01-29 |
$33,268,000 |
| 10137130 |
Methods of treatment of malignancies |
Michael Amatangelo, Xiaolan Hu, Anjan Thakurta, Sung Eun Choe |
2018-11-27 |
$271,866,000 |
| 9394297 |
Amides as pim inhibitors |
Victor J. Cee, Frank Chavez, Jian Chen, Essa Hu Harrington, Bradley J. Herberich +11 more |
2016-07-19 |
$599,206,000 |
| 9321756 |
Azole compounds as PIM inhibitors |
Hui-Ling Wang, Victor J. Cee, Bradley J. Herberich, Claire L. M. Jackson, Brian Alan LANMAN +5 more |
2016-04-26 |
$193,059,000 |
| 9187486 |
Bicyclic pyridazine compounds as Pim inhibitors |
Derin D'Amico, Bradley J. Herberich, Claire L. M. Jackson, Liping H. Pettus, Andrew Tasker +2 more |
2015-11-17 |
$611,279,000 |
| 9090593 |
Bicyclic compounds as Pim inhibitors |
Hui-Ling Wang, Kaustav Biswas, Victor J. Cee, Frank Chavez, Bradley J. Herberich +10 more |
2015-07-28 |
$306,601,000 |
| 8772480 |
Inhibitors of PI3 kinase and/or mTOR |
Kristin L. Andrews, Yunxin Y. Bo, Shon Booker, Victor J. Cee, Noel D'Angelo +15 more |
2014-07-08 |
$117,483,000 |
| 8754192 |
Compositions comprising homogeneously glycosylated erythropoietin |
Samuel J. Danishefsky, J. David Warren, Jiehao Chen, Gong Chen, Qian Wan +6 more |
2014-06-17 |
|
| 8455495 |
Pyridazino-pyridinone compounds and methods of use |
Liping H. Pettus, Andrew Tasker, Hui-Ling Wang, Ryan Wurz |
2013-06-04 |
$86,106,000 |
| 8420649 |
Pyrido[3,2-d]pyridazine-2(1H)-one compounds as p38 modulators and methods of use thereof |
Liping H. Pettus, Andrew Tasker |
2013-04-16 |
$108,535,000 |
| 7993832 |
Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders |
Steven A. Rosenberg, Kirk Fry, Russell L. Dedrick |
2011-08-09 |
|
| 6974867 |
Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers |
Todd W. Seeley, Lewis T. Williams |
2005-12-13 |
$52,518,000 |
